Last Price
0.094
Today's Change
+0.004 (4.44%)
Day's Change
0.087 - 0.096
Trading Volume
4,902,774
Exchange: NASDAQ Global Market NASDAQ Global Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. David Joszef Tapolczay Dr. David Joszef Tapolczay
Full Time Employees: 7 7
IPO Date: 2022-03-28 2022-03-28
CIK: 0001896212 0001896212
ISIN: US20678X1063 US20678X1063
CUSIP: 20678X106 20678X106
Beta: 2.12 2.12
Last Dividend: 0.00 0.00
Dcf Diff: 0.05 0.05
Dcf: 0.05 0.05
Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.